Shareholder Alert: Ademi LLP investigates whether Infinity Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MEI Pharma

Provided By PR Newswire

Last update: Feb 23, 2023

MILWAUKEE, Feb. 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Infinity (NASDAQ: INFI) for possible breaches of fiduciary duty and other violations of law in its transaction with MEI Pharma.